Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2019 Q2- Text added to 2019 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
New words:
abnormal, Amsel, avoiding, bioadhesive, Biotech, cervix, clearance, clue, confirmed, consent, consummated, consummation, counted, covenant, criteria, curtail, deactivated, discharge, disrupt, dissenting, diverted, economic, endpoint, epithelial, forma, gel, genitalia, healthy, home, hydroxide, implant, implantable, IND, individual, insufficient, issuable, KOH, levonorgestrel, median, Merck, met, metronidazole, midcycle, mount, multicenter, mutual, nonclinical, NuvaRing, oral, ovulatory, pendency, placebo, postmenarchal, potassium, precise, precisely, presence, proportion, proposition, PT, randomized, Recent, requisite, resolution, resolved, saline, schedule, store, suppression, system, systemic, thermosetting, toxicology, traditional, triangular, true, unexpected, unparalleled, user, vulva, wet, whiff, wirelessly
Valuein 2019 Q2 filing- Value in 2019 Q3 filing
Original filings
Filing view